The full content of Annals is available to subscribers

Subscribe/Learn More  >
Reviews |

Pancreatic Islet Cell Carcinoma: II. Results of Therapy with Streptozotocin in 52 Patients

[+] Article, Author, and Disclosure Information

▸Requests for reprints should be addressed to Stephen K. Carter, M.D., Cancer Therapy Evaluation Branch, Division of Cancer Treatment, National Cancer Institute, Building 37/6A17, Bethesda, MD 20014.

Ann Intern Med. 1973;79(1):108-118. doi:10.7326/0003-4819-79-1-108
Text Size: A A A

The clinical experience with streptozotocin (NSC-85998) in 52 patients with metastatic islet cell carcinoma was analyzed. The drug was given intravenously in 44 patients and intra-arterially in 8 patients, most often on a weekly schedule of administration of 0.6 to 1.0 g/m2 body surface area. Biochemical responses were seen in 64% of evaluable functional cases, and measurable disease responses were seen in 50% of these cases. Insulin responses occurred 2 to 3 weeks after drug administration at a total dose of about 2 to 4 g/m2 body surface area. A significant increase in 1-year survival rate and a doubling of median survival were shown for the responders as compared with the nonresponders. Acute toxicity, consisting of nausea and vomiting, was observed in 98% of the cases, whereas renal or hepatic toxicity was seen in 65% and 67% of the cases, respectively. Hematological toxicity, observed in 20% of the cases, was mild. Renal and hepatic toxicity were usually reversible, but five patients died in renal failure.





Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).


Submit a Comment/Letter
Submit a Comment/Letter

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.


Buy Now for $42.00

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Related Articles
Topic Collections
PubMed Articles
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.